Capital Impact Advisors, LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 166 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital Impact Advisors, LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$488,644
+26.6%
25,136
+84.7%
0.54%
+13.5%
Q1 2023$386,031
+4.0%
13,607
+7.1%
0.47%
+30.6%
Q4 2022$371,338
-20.1%
12,7040.0%0.36%
-21.6%
Q3 2022$465,000
-10.7%
12,704
+8.3%
0.46%
-3.7%
Q2 2022$521,000
-33.9%
11,728
-26.3%
0.48%
-16.1%
Q1 2022$788,000
-19.8%
15,918
-17.4%
0.57%
-15.4%
Q4 2021$982,000
-8.7%
19,2760.0%0.68%
+58.9%
Q3 2021$1,075,000
+30.3%
19,2760.0%0.43%
+60.2%
Q2 2021$825,000
-44.8%
19,276
-46.2%
0.27%
-49.1%
Q1 2021$1,495,000
-10.4%
35,8150.0%0.52%
+27.6%
Q4 2020$1,668,000
+9.7%
35,8150.0%0.41%
-9.1%
Q3 2020$1,521,000
-11.5%
35,8150.0%0.45%
-21.4%
Q2 2020$1,718,000
+4.3%
35,8150.0%0.57%
-17.1%
Q1 2020$1,647,000
-18.7%
35,815
+6.2%
0.69%
-2.9%
Q4 2019$2,026,000
+6.5%
33,7250.0%0.71%
-1.7%
Q3 2019$1,903,000
-1.6%
33,725
-4.1%
0.72%
+2.4%
Q2 2019$1,933,000
+45.2%
35,149
+3.6%
0.71%
+20.0%
Q1 2019$1,331,0000.0%33,9390.0%0.59%
+3.7%
Q4 2018$1,331,000
-19.8%
33,939
+40.9%
0.57%0.0%
Q3 2018$1,660,000
-9.2%
24,0840.0%0.57%
-15.8%
Q2 2018$1,829,000
+31.9%
24,084
-8.5%
0.68%
+18.6%
Q1 2018$1,387,00026,3170.57%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
JW Asset Management, LLC 475,755$25,068,00024.71%
Hudson Executive Capital LP 971,000$51,162,00015.09%
Park West Asset Management LLC 1,051,274$55,392,0002.47%
U S GLOBAL INVESTORS INC 19,200$1,012,0000.62%
Capital Impact Advisors, LLC 26,317$1,387,0000.57%
CLARK ESTATES INC/NY 56,278$2,965,0000.47%
IRIDIAN ASSET MANAGEMENT LLC/CT 873,131$46,005,0000.41%
ProQuest Associates IV LLC 6,777$357,0000.41%
Granite Investment Partners, LLC 114,207$6,017,0000.40%
GLOBEFLEX CAPITAL L P 30,900$1,628,0000.34%
View complete list of EAGLE PHARMACEUTICALS INC shareholders